Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024
Heron Therapeutics (HRTX) has scheduled its third quarter 2024 financial results conference call and webcast for Tuesday, November 12, 2024, at 8:00 a.m. ET. The event will include a discussion of recent business highlights. Participants are encouraged to dial in fifteen minutes before the start time to avoid delays. The webcast will be available under the Investor Relations section of Heron's website, with a replay accessible for 60 days following the call.
Heron Therapeutics (HRTX) ha programmato la sua call e webcast sui risultati finanziari del terzo trimestre 2024 per martedì 12 novembre 2024, alle 8:00 a.m. ET. L'evento includerà una discussione sui recenti punti salienti dell'attività. I partecipanti sono incoraggiati a collegarsi quindici minuti prima dell'orario di inizio per evitare ritardi. Il webcast sarà disponibile nella sezione Relazioni con gli Investitori del sito web di Heron, con una registrazione accessibile per 60 giorni dopo la chiamata.
Heron Therapeutics (HRTX) ha programado su conferencia y webcast sobre los resultados financieros del tercer trimestre de 2024 para el martes 12 de noviembre de 2024, a las 8:00 a.m. ET. El evento incluirá una discusión sobre los recientes aspectos destacados del negocio. Se alienta a los participantes a llamar quince minutos antes de la hora de inicio para evitar demoras. El webcast estará disponible en la sección de Relaciones con Inversores del sitio web de Heron, con una repetición accesible durante 60 días después de la llamada.
헤론 테라퓨틱스 (HRTX)는 2024년 3분기 재무 결과에 대한 컨퍼런스 콜 및 웹캐스트를 2024년 11월 12일 화요일 오전 8시(ET)에 예정했습니다. 이 이벤트는 최근 비즈니스 주요 사항에 대한 논의를 포함합니다. 참가자들은 지연을 피하기 위해 시작 15분 전에 전화를 걸도록 권장됩니다. 웹캐스트는 헤론 웹사이트의 투자자 관계 섹션에서 이용 가능하며, 호출 후 60일 동안 재생이 가능합니다.
Heron Therapeutics (HRTX) a prévu sa conférence téléphonique et webcast sur les résultats financiers du troisième trimestre 2024 pour mardi 12 novembre 2024, à 8h00 ET. L'événement comprendra une discussion sur les points forts récents de l'entreprise. Les participants sont encouragés à se connecter quinze minutes avant l'heure de début pour éviter les retards. Le webcast sera disponible dans la section Relations Investisseurs du site Web de Heron, avec une rediffusion accessible pendant 60 jours après l'appel.
Heron Therapeutics (HRTX) hat seine Konferenzschaltung und Webcast zu den Finanzresults des dritten Quartals 2024 für Dienstag, den 12. November 2024, um 8:00 Uhr ET angesetzt. Die Veranstaltung wird eine Diskussion über die jüngsten Geschäftshighlights umfassen. Teilnehmer werden ermutigt, sich fünfzehn Minuten vor Beginn einzuwählen, um Verzögerungen zu vermeiden. Der Webcast wird im Bereich der Investor Relations auf der Webseite von Heron verfügbar sein, mit einem Rückblick, der 60 Tage nach dem Anruf zugänglich ist.
- None.
- None.
The conference call can be accessed by phone by utilizing the following registration link which will provide participants with dial-in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The conference call will also be available via webcast under the Investor Relations section of Heron's website at www.herontx.com. An archive of the teleconference and webcast will also be made available on Heron's website for 60 days following the call.
About Heron Therapeutics, Inc.
Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. For more information, visit www.herontx.com.
Forward-looking Statements
This news release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Heron cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, but are not limited to, risks and uncertainties identified in the Company's filings with the Securities and Exchange Commission. Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or revise these statements except as may be required by law.
Investor Relations and Media Contact:
Ira Duarte
Executive Vice President, Chief Financial Officer
Heron Therapeutics, Inc.
iduarte@herontx.com
858-251-4400
View original content to download multimedia:https://www.prnewswire.com/news-releases/heron-therapeutics-to-report-third-quarter-2024-financial-results-on-tuesday-november-12-2024-302290555.html
SOURCE Heron Therapeutics, Inc.
FAQ
When will Heron Therapeutics (HRTX) report Q3 2024 earnings?
How can I access Heron Therapeutics (HRTX) Q3 2024 earnings call?
How long will Heron Therapeutics (HRTX) Q3 2024 earnings call replay be available?
